title: Deciphering Antigenic Determinants of Streptococcus pneumoniae Serotype 4 Capsular Polysaccharide using Synthetic Oligosaccharides.
abstract: Streptococcus pneumoniae is a major cause of mortality and morbidity worldwide. More than 90 S. pneumoniae serotypes are distinguished based on the structure of their primary targets to the human immune system, the capsular polysaccharides (CPSs). The CPS of the prevalent serotype 4 (ST4) is composed of tetrasaccharide repeating units and is included in existing pneumococcal vaccines. Still, the structural antigenic determinants that are essential for protective immunity, including the role of the rare and labile cyclic trans-(2,3) pyruvate ketal modification, remain largely unknown. Molecular insights will support the design of synthetic subunit oligosaccharide vaccines. Here, we identified the key antigenic determinants of ST4 CPS with the help of pyruvated and nonpyruvated synthetic repeating unit glycans. Glycan arrays revealed oligosaccharide antigens recognized by antibodies in the human reference serum. Selected depyruvated ST4 oligosaccharides were used to formulate neoglycoconjugates and immunologically evaluated in mice. These oligosaccharides were highly immunogenic, but the resulting antiglycan antibodies showed only limited binding to the natural CPS present on the bacterial surface. Glycan array and surface plasmon resonance analysis of murine polyclonal serum antibodies as well as monoclonal antibodies revealed that terminal sugars are important in directing the immune responses. The pyruvate modification on the oligosaccharide is needed for cross-reactivity with the native CPS. These findings are an important step toward the design of oligosaccharide-based vaccines against S. pneumoniae ST4.
authors.affiliation: Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , Am Mühlenberg 1, 14424 Potsdam, Germany.|Institute for Chemistry and Biochemistry, Freie Universität Berlin , Arnimallee 22, 14195 Berlin, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Geissner
authors.affiliation: Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , Am Mühlenberg 1, 14424 Potsdam, Germany.
authors.forename: Claney L
authors.initials: CL
authors.lastname: Pereira
authors.affiliation: Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , Am Mühlenberg 1, 14424 Potsdam, Germany.
authors.forename: Melanie
authors.initials: M
authors.lastname: Leddermann
authors.affiliation: Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , Am Mühlenberg 1, 14424 Potsdam, Germany.
authors.forename: Chakkumkal
authors.initials: C
authors.lastname: Anish
authors.affiliation: Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , Am Mühlenberg 1, 14424 Potsdam, Germany.|Institute for Chemistry and Biochemistry, Freie Universität Berlin , Arnimallee 22, 14195 Berlin, Germany.
authors.forename: Peter H
authors.initials: PH
authors.lastname: Seeberger
mesh_terms: D000818:Animals; D016667:Bacterial Capsules / Q000737:chemistry / Q000276:immunology*; D002240:Carbohydrate Sequence; D000939:Epitopes / Q000737:chemistry / Q000276:immunology*; D005260:Female; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D011008:Pneumococcal Infections / Q000276:immunology / Q000382:microbiology*; D011135:Polysaccharides, Bacterial / Q000737:chemistry / Q000276:immunology*; D065288:Serogroup; D013296:Streptococcus pneumoniae / Q000737:chemistry / Q000276:immunology*
chemical_list: D000939:Epitopes; D011135:Polysaccharides, Bacterial